Because PSA secretion is tightly regulated by luminal epithelial cell activity and decreases when viable prostate cancer cells are lost, we hypothesize that the biological mechanism underlying PSA decline in vivo mirrors the reduction in organoid viability observed in vitro [2,6,7]. The gene discussed is KLK3; the disease is prostate carcinoma.